Corcept Therapeutics Incorporated (CORT) Ownership

$51.66

north_east
$0.81 (1.58%)
Day's range
$49.8
Day's range
$51.78

Corcept Therapeutics Incorporated Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK FUNDING, INC. /DE 02/07/2025 15.68 M $789.98 M   -2.32% 15.17%
VANGUARD GROUP INC 02/11/2025 10.12 M $509.73 M   1.09% 9.79%
INGALLS & SNYDER LLC 01/29/2025 8.10 M $408.15 M   -2.02% 7.84%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 6.20 M $312.35 M   -4.77% 6.00%
PARALLEL ADVISORS, LLC 02/10/2025 3.83 M $192.98 M   0.42% 3.70%
STATE STREET CORP 02/14/2025 3.55 M $178.80 M   0.83% 3.43%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 2.08 M $104.74 M   -17.92% 2.01%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 2.07 M $104.24 M   -13.06% 2.00%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 02/12/2025 1.64 M $82.89 M   4.07% 1.59%
FMR LLC 02/13/2025 1.34 M $67.38 M   -1.97% 1.29%
FIRST TRUST ADVISORS LP 02/13/2025 1.06 M $53.62 M   -19.27% 1.03%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 1.05 M $52.99 M   2.44% 1.02%
BOSTON TRUST WALDEN CORP 01/24/2025 899,061 $45.30 M   -40.62% 0.87%
D. E. SHAW & CO., INC. 02/14/2025 886,576 $44.67 M   12.50% 0.86%
NORGES BANK 02/12/2025 834,591 $42.06 M   100.00% 0.81%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2025 796,795 $40.15 M   -7.30% 0.77%
INVESCO LTD. 02/13/2025 706,133 $35.58 M   -17.64% 0.68%
GOLDMAN SACHS GROUP INC 02/11/2025 626,246 $31.56 M   32.39% 0.61%
CERITY PARTNERS LLC 02/13/2025 607,946 $30.60 M   -0.63% 0.59%
BANK OF NEW YORK MELLON CORP 02/04/2025 589,771 $29.72 M   -2.58% 0.57%
PRINCIPAL FINANCIAL GROUP INC 01/31/2025 517,332 $26.07 M   4.37% 0.50%
MILLENNIUM MANAGEMENT LLC 02/14/2025 508,357 $25.62 M   112.50% 0.49%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 500,000 $25.20 M   100.00% 0.48%
CLEARBRIDGE INVESTMENTS, LLC 02/12/2025 481,389 $24.26 M   -9.80% 0.47%
BURNEY CO/ 01/14/2025 473,821 $23.88 M   9.13% 0.46%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 02/14/2025 471,623 $23.77 M   -24.20% 0.46%
SYNERGY ASSET MANAGEMENT, LLC 01/23/2025 462,411 $22.37 M   131.31% 0.45%
ABRDN PLC 01/24/2025 435,895 $21.96 M   -34.64% 0.42%
QUBE RESEARCH & TECHNOLOGIES LTD 02/14/2025 412,259 $20.77 M   604.37% 0.40%
TWO SIGMA ADVISERS, LP 02/14/2025 381,800 $19.24 M   -16.47% 0.37%
ROYCE & ASSOCIATES LP 02/10/2025 338,300 $17.05 M   -6.87% 0.33%
AMERIPRISE FINANCIAL INC 02/14/2025 317,318 $15.99 M   -19.11% 0.31%
FAS WEALTH PARTNERS, INC. 02/14/2025 309,207 $15.58 M   -2.07% 0.30%
BARCLAYS PLC 02/13/2025 305,000 $15.37 M   52.50% 0.30%
JANUS HENDERSON GROUP PLC 02/14/2025 301,490 $15.19 M   -6.95% 0.29%
BRAUN STACEY ASSOCIATES INC 01/31/2025 296,390 $14.94 M   100.00% 0.29%
MAN GROUP PLC 02/14/2025 287,880 $14.51 M   -17.87% 0.28%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 285,200 $14.37 M   -31.19% 0.28%
LEGAL & GENERAL GROUP PLC 02/13/2025 278,149 $14.02 M   0.00% 0.27%
AQR CAPITAL MANAGEMENT LLC 02/14/2025 276,591 $13.94 M   -12.46% 0.27%
FRANKLIN RESOURCES INC 02/12/2025 273,974 $13.81 M   12.84% 0.27%
JPMORGAN CHASE & CO 02/12/2025 259,902 $13.10 M   2.70% 0.25%
UBS GROUP AG 02/14/2025 250,162 $12.61 M   40.39% 0.24%
RAYMOND JAMES FINANCIAL INC 02/13/2025 239,803 $12.08 M   100.00% 0.23%
PUBLIC SECTOR PENSION INVESTMENT BOARD 02/14/2025 232,334 $11.71 M   17.76% 0.22%
M&G PLC 02/11/2025 228,211 $11.41 M   -6.05% 0.22%
UBS ASSET MANAGEMENT AMERICAS INC 02/14/2025 224,713 $11.32 M   11.05% 0.22%
VOYA INVESTMENT MANAGEMENT LLC 02/14/2025 222,750 $11.22 M   1.43% 0.22%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 220,679 $11.12 M   -0.63% 0.21%
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 02/05/2025 219,905 $11.08 M   -15.01% 0.21%

Corcept Therapeutics Incorporated institutional Ownership - FAQ's

During the previous two years, 454 institutional investors and hedge funds held shares of Corcept Therapeutics Incorporated. The most heavily invested institutionals were:

BlackRock Funding, Inc. /DE: 15.68 M

VANGUARD GROUP INC: 10.12 M

INGALLS & SNYDER LLC: 8.1 M

RENAISSANCE TECHNOLOGIES LLC: 6.2 M

Parallel Advisors, LLC: 3.83 M

STATE STREET CORP: 3.55 M

81.50% of Corcept Therapeutics Incorporated stock is owned by institutional investors.

Institutional investors have bought a total of 111.37 M shares in the last 24 months. This purchase volume represents approximately $5.75 B in transactions.